Physiologically based toxicokinetic modeling of secondary acute myelolytic leukemia

Environmental Toxicology and Pharmacology

Volumn 37, Issue 1, 2014, Pages 378-389

  Mukhopadhyay, Manas Kumar ^a   Nath, Debjani ^a  

^a UNIVERSITY OF KALYANI   (India)

Author keywords

Benzene exposure; Hematotoxicity; Secondary AML; Survival analysis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BENZENE; CELL CYCLE PROTEIN; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN E; HEMOGLOBIN; PROTEIN P21; PROTEIN P53;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE REGULATION; CELL STRUCTURE; CHROMOSOME ABERRATION; CLINICAL FEATURE; COMET ASSAY; CONTROLLED STUDY; DNA FRAGMENTATION; DOWN REGULATION; ENZYME BLOOD LEVEL; ERYTHROCYTE; HEMATOPOIETIC CELL; LEUKOCYTE COUNT; LIVER CELL; LIVER HISTOLOGY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE; TOXICOKINETICS; UPREGULATION; WESTERN BLOTTING;

BENZENE EXPOSURE; HEMATOTOXICITY; SECONDARY AML; SURVIVAL ANALYSIS;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BENZENE; BONE MARROW CELLS; CARCINOGENS; CELL CYCLE PROTEINS; CHROMOSOME ABERRATIONS; DISEASE MODELS, ANIMAL; DNA FRAGMENTATION; ERYTHROCYTE INDICES; HEMATOCRIT; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTE COUNT; LIVER; MALE; MICE;

EID: 84892463046     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2013.11.029     Document Type: Article

References (61)

1. Abraham N.G. Hematopoietic effects of benzene inhalation assessed by long-term bone marrow culture. Environ. Health Perspect. 1996, 104(Suppl. 6):1277-1282.
2. Aksoy M., Erdem S., Dincol G. Leukemia in shoe-workers exposed chronically to benzene. Blood 1974, 44:837-841.
3. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:3983-3988.
4. Balasubramaniam P., Malathi A. Comparative study of hemoglobin estimated by Drabkin's and Sahli's methods. J. Postgrad. Med. 1992, 38:8-38.
5. Bergmeyer H.U., Brent E. Methods of Enzymatic Analysis, vol. 2 1974, 574-578. Academic Press, New York.
6. Beurlet S., Chomienne C., Ann Padua R. Engineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they?. J. Haematol. 2013, 98(1):10-22.
7. Bradford M.M. Rapid and sensitive method for the quantization of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
8. Carballo M., Nigro M.L., Fraga I., Gadano A. Ethylene oxide: cytogenetic and biochemical studies in persons occupationally exposed. Environ. Mol. Mutagen. 1994, 23:7-12.
9. Charles H., Won S.K., Reed S.I. Deregulated cyclin E induces chromosome instability. Nature 1999, 401(6750):297-300.
10. Chen H., Eastmond D.A. Synergistic increase in chromosomal breakage within the euchromatin induced by an interaction of the benzene metabolites phenol and hydroquinone in mice. Carcinogenesis 1995, 16(8):1963-1969.
11. Choudhuri T., Pal S., Das T., Sa G. Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. J. Biol. Chem. 2005, 280(20):20059-20068.
12. Cormack E.M., Bruserud Ø., Gjertsen B.T. Animal models of acute myelogenous leukaemia-development, application and future perspectives. Leukemia 2005, 19:687-706.
13. Cronkite E.P., Inoue T., Carsten A.L., Miller M.E., Bullis J.E., Drew R.T. Effects of benzene inhalation on murine pluripotent stem cells. J. Toxicol. Environ. Health 1982, 9(3):411-421.
14. Cronkite E.P., Bullis J., Inoue T., Drew R.T. Benzene inhalation produces leukemia in mice. Toxicol. Appl. Pharmacol. 1984, 75:358-361.
15. Cronkite E.P. Benzene hematotoxicity and leukemogenesis. Blood Cells 1986, 12(1):129-137.
16. Cronkite E.P., Drew R.T., Inoue T., Hirabayashi Y., Bullis J.E. Hematotoxicity and carcinogenicity of inhaled benzene. Environ. Health Perspect. 1989, 82:97-108.
17. Curt G.A. The use of animal models in cancer drug discovery and development. Stem Cells 1994, 12:23-29.
18. Dick J.E., Kamel-Reid S., Murdoch B., Doedens M. Gene transfer into normal human hematopoietic cells using in vitro and in vivo assays. Blood 1991, 78:624-634.
19. Eastmond D.A., Smith M.T., Irons R.D. An interaction of benzene metabolites reproduces the myelotoxicity observed with benzene exposure. Toxicol. Appl. Pharmacol. 1987, 91(1):85-95.
20. Farris G.M., Robinson S.N., Gaido K.W., Wong B.A., Wong V.A., Hahn W.P., Shah R.S. Benzene-induced hematotoxicity and bone marrow compensation in B6C3F1 mice. Fundam. Appl. Toxicol. 1997, 36:119-129.
21. Farris G.M., Everitt J.I., Irons R.D., Popp J.A. Carcinogenicity of inhaled benzene in CBA mice. Fundam. Appl. Toxicol. 1993, 20(4):503-507.
22. Gedik C.M., Ewen S.W., Collins A.R. Single-cell gel electrophoresis applied to the analysis of UV-C damage and its repair in human cells. Int. J. Radiat. Biol. 1992, 62(3):313-320.
23. Green J.D., Snyder C.A., LoBue J., Goldstein B.D., Albert R.E. Acute and chronic dose/response effects of inhaled benzene on multipotential hematopoietic stem (CFU-S) and granulocyte/macrophage progenitor (GM-CFU-C) cells in CD-1 mice. Toxicol. Appl. Pharmacol. 1981, 58(3):492-503.
24. Hagenbeek A., Martens A.C. Minimal residual disease in acute leukaemia: preclinical studies in a relevant rat model (BNML). Baillieres Clin. Haematol. 1991, 4(3):609-635.
25. Huff J.E., Haseman J.K., DeMarini D.M., Eustis S., Maronpot R.R., Peters A.C., Persing R.L., Chrisp C.E., Jacobs A.C. Multiple-site; carcinogenicity of benzene in Fischer 344 rats and B6C3F1 mice. Environ. Health Perspect. 1989, 82:125-163.
26. Kamel-Reid S., Dick J.E. Engraftment of immune-deficient mice with human hematopoietic stem cells. Science 1988, 242:1706-1709.
27. Kawasaki Y., Hirabayashi Y., Yoon B.I., Huo Y., Kaneko T., Kurokawa Y., Inoue T. Benzene inhalation induced an early onset and a high incidence of leukemias in the p53 deficient C57BL/6 mice. Jpn. J. Cancer Res. 2001, 92(Suppl.):71.
28. Larson R.A. Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?. Best Pract. Res. Clin. Haematol. 2007, 20(1):29-37.
29. Lundberg A.S., Weinberg R.A. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin CDK complexes. Mol. Cell. Biol. 1998, 18:753-761.
30. Maltoni C., Ciliberti A., Cotti G., Conti B., Belpoggi F. Benzene, an experimental multipotential carcinogen: results of the long-term bioassays performed at the Bologna Institute of Oncology. Environ. Health Perspect. 1989, 82:109-124.
31. Malumbres M., Sotillo R., Santamaría D., Galá n J., Cerezo A., Ortega S., Dubus P., Barbacid M. Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell 2004, 118:493-504.
32. McCune J.M., Namikawa R., Kaneshima H., Shultz L.D., Lieberman M., Weissman I.L. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 1988, 241:1632-1639.
33. McCormack E., Bruserud O., Gjertsen B.T. Animal models of acute myelogenous leukaemia development, application and future perspectives. Leukemia 2005, 19(5):687-706.
34. Mendiratta D.K., Bhutada K., Narang R., Narang P. Evaluation of different methods for diagnosis of P. falciparum malaria. Indian J. Med. Microbiol. 2006, 24(1):49-51.
35. Mombaerts P., Iacomini J., Johnson R.S., Herrup K., Tonegawa S., Papaioannou V.E. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 1992, 68:869-877.
36. Mosier D.E., Gulizia R.J., Torbett B.E., Baird S.M., Wilson D.B. Break for SCIDs. Nature 1991, 353:509.
37. Mosier D.E., Gulizia R.J., Baird S.M., Wilson D.B. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988, 335:256-259.
38. Mule J.J., Jicha D.L. The use of Rosenberg SA congenitally immunodeficient mice to study human tumor metastases and immunotherapy. J. Immunother. 1992, 12:196-198.
39. Natelson E.A. Benzene-induced acute myeloid leukemia: a clinician's perspective. Am. J. Hematol. 2007, 82:826-830.
40. Price J.E., Polyzos A., Zhang R.D., et al. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res. 1990, 50:717-721.
41. Rabble G.K., Wong O. Leukaemia mortality by cell type in petroleum workers with potential exposure to benzene. Environ. Health Perspect. 1996, 104:1381-1392.
42. Ricci-Vitini L., Lombardi D.G., Pilozzi E., Biffoni M., Todardo M. Identification and expression of human colon cancer-initiating cells. Nature 2007, 445:111-115.
43. Sarma P.R. Red cell indices. Clinical Methods: The History, Physical, and Laboratory Examinations 1990, Butterworths, Boston. 3rd ed. H.K. Walker, W.D. Hall, J.W. Hurst (Eds.).
44. Sharma V., Pandey D. Beneficial effects of Tinospora cordifolia on blood profiles in male mice exposed to lead. Toxicol. Int. 2010, 17:8-11.
45. Shinkai Y., Rathbun G., Lam K.P., Oltz E.M., Stewart V., Mendelsohn M. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992, 68:855-867.
46. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., et al. Identification of human brain tumor initiating cells. Nature 2004, 432:396-401.
47. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 1988, 175:184-191.
48. Smith M. T Overview of benzene-induced aplastic anaemia. Eur. J. Haematol. 1996, 57(Suppl.):107-110.
49. Smith M.T. The mechanism of benzene-induced leukemia: a hypothesis and speculations on the causes of leukemia. Environ. Health Perspect. 1996, 104(6):1219-1225.
50. Smith M.T., Yager J.W., Steinmetz K.L., Eastmond D.A. Peroxidase-dependent metabolism of benzene's phenolic metabolites and its potential role in benzene toxicity and carcinogenicity. Environ. Health Perspect. 1989, 82:23-29.
51. Smith M.T., Zhang L., McHale C.M., Skibola C.F., Rappapor S.M. Benzene, the exposome and future investigations of leukemia etiology. Chemico-Biol. Interact. 2011, 192(1-2):155-159.
52. Snyder C.A., Goldstein B.D., Sellakumar A.R., Bromberg I., Laskin S., Albert R.E. The inhalation toxicology of benzene: Incidence of hematopoietic neoplasms and hematotoxicity in ARK/J and C57BL/6J mice. Toxicol. Appl. Pharmacol. 1980, 54:323-331.
53. Subrahmanyam V.V., Doane-Setzer P., Steinmetz K.L., Ross D., Smith M.T. Phenol-induced stimulation of hydroquinone bioactivation in mouse bone marrow in vivo: possible implications in benzene myelotoxicity. Toxicology 1990, 62(1):107-116.
54. Tuo J., Loft S., Thomsen M.S., Poulsen H.E. Benzene induced genotoxicity in mice in vivo detected by the alkaline comet assay: reduction by CYP2E1 inhibition. Mutat. Res. 1996, 368:213-219.
55. Uno S., Dalton T.P., Derkenne S., Curran C.P., Miller M.L., Shertzer H.G., Nebert D.W. Oral exposure to benzo[a] pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation. Mol. Pharmacol. 2004, 65:1225-1237.
56. Vardiman J., Brunning R., Arber D. Introduction and overview of the classify cation of the myeloid neoplasms. WHO Classification of Tumours: Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues 2008, 18-30. IARC Press, Lyon, France. S. Swerdlow, E. Campo, N. Harris (Eds.).
57. Wolman S.R. Cytologic and cytogenetic effects of benzene. J. Toxicol. Environ. Health Suppl. 1977, 2:63-68.
58. Hirabayashi Y., Inoue T. Benzene-induced bone-marrow toxicity: a hematopoietic stem-cell-specific, aryl hydrocarbon receptor-mediated adverse effect. Chemico-Biol. Interact. 2010, 184:252-258.
59. Yoon B.I., Hirabayashi Y., Kawasaki Y., Kodama Y., Kaneko T., Kim D.Y., Inoue T. Mechanism of action of benzene toxicity: cell cycle suppression in hemopoietic progenitor cells (CFU-GM). Exp. Hematol. 2001, 29:278-285.
60. Yoon B.I., Li G.-X., Kitada K., Kawasaki Y., Igarashi K., Kodama Y., Inoue T., Kobayashi K., Kanno J., Kim D.-Y., Hirabayashi Y. Mechanisms of benzene-induced hematotoxicity and leukemogenicity: cDNA microarray analyses using mouse bone marrow tissue. Environ. Health Perspect. 2003, 111(11):1411-1420.
61. Zuber J., Radtke I., Pardee T.S., Zhao Z., Rappaport A.R., Luo W., McCurrach M.E., Yang M.-M., Dolan M.E., Kogan S.C., Downing J.R., Lowel S.W. Mouse models of human AML accurately predict chemotherapy response. Genes Dev. 2009, 23:877-899.